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Bacterial natural products such as nonribosomally syn­
the  sized peptides and polyketides are widely appreciated 
as biologically active agents, in part because they include 
many  pharmaceuticals.  Because  their  synthesis  is  en­
coded by large, highly conserved genes, their presence, 
distribution  and  abundance  is  easily  assessed.  By 
contrast,  although  the  study  of  biologically  active 
ribosomally  synthesized  peptides  ­  ribosomal  peptide 
natural products ­ has a long and rich history, the true 
structural diversity of these compounds is just beginning 
to  be  appreciated.  In  a  recent  paper  in  BMC  Biology, 
Haft,  Basu  and  Mitchell  [1]  report  on  informatics 
methods  to  uncover  cryptic  diversity  in  ribosomal 
peptide natural products, and in the process discover two 
widely  occurring  new  families.  Within  these  families, 
there  are  numerous  precursor  peptides  with  hyper­
variable  sequences.  These  precursors  can  likely  act  as 
substrates  for  the  processing  pathways,  and  so  each 
pathway leads to numerous different peptides. This work 
and  other  recent  studies  suggest  that  the  ribosomal 
peptide natural products represent a largely hidden arsenal 
of  active  small  molecules  that  are  important  in  micro­
biology, the environment, medicine and technology.
Synthesis of ribosomal peptide natural products
Ribosomal  peptide  natural  products  are  derived  from 
short  precursor  peptides,  most  commonly  around  100 
amino acids long, that are posttranslationally modified by 
various enzymes that catalyze the formation of a large 
number  of  different  chemical  motifs  (Figure  1)  [2,3]. 
Commonly,  the  precursor  peptide  contains  a  relatively 
conserved leader sequence that is at least partly respon­
sible for recognition by the modifying enzymes and/or by 
export  machinery  such  as  ABC  transporters.  The 
carboxyl terminus of the precursor peptide encodes the 
sequence that is enzyme­modified (the ‘core sequence’). 
Usually, the leader is cleaved from the mature carboxyl 
terminus  following  modification,  resulting  in  a  short 
peptide product. Mutations in the carboxy­terminal core 
sequence  are  often  tolerated  by  modifying  enzymes, 
leading to natural libraries of peptide products [4]. These 
biosynthetic trends are nearly universal for the bacterial 
ribosomal  peptide  natural  products  and  are  also 
commonly found in the biosynthesis of similar peptides 
from other organisms such as cone snails and fungi.
Despite these biosynthetic relationships, enzymes and 
precursor peptides are often not clearly homologous. In 
addition,  the  bacterial  ribosomal  peptide  literature  is 
frag  mented.  These  natural  products  were  originally 
described  as  ‘bacteriocins’,  peptides  that  inhibited  the 
growth of bacteria closely related to the producing strain. 
Low­molecular­weight  bacteriocins  include  the  lanti­
biotics  and  the  microcins,  which  are  highly  post­
translationally  modified  peptides  that  in  some  ways 
resemble their nonribosomally synthesized cousins ([2] 
and  references  therein).  A  major  problem  with  this 
nomenclature,  however,  is  that  many  bacteriocins  are 
proteins unrelated to the small­molecule bacteriocins. In 
addition,  many  of  the  ribosomal  peptides  exhibit 
strikingly  different  activities  from  those  conventionally 
ascribed to bacteriocins, including roles in the induction 
of  genetic  competence,  quorum  sensing  and  enzyme 
catalysis  (as  small­molecule  redox  cofactors).  Some 
peptides show in vitro activity against mammalian cells 
but  not  against  bacteria  or  fungi,  and  the  biological 
function  of  many  others  is  unknown.  The  enormous 
number  of  structural  classes  and  of  molecules  within 
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different biological roles that have yet to be investigated. 
The report by Haft et al. [1] directly demonstrates the 
complexity  and  interrelatedness  of  the  lantibiotic  and 
microcin groups and will help in the push to consolidate 
the literature and to understand the biological roles of 
these ubiquitous compounds.
Making connections among the heterocyclic 
natural products
The  genes  for  ribosomal  peptide  natural  products  are 
hard to find, especially in the absence of any chemical or 
bioactivity information. The precursor peptides are small 
and  often  only  distantly  related  to  other  precursor 
peptides, and so are often not called as coding sequences 
in  automatic  genome  annotation  [5].  Similarly,  new 
families  of  modifying  enzymes  are  often  not  closely 
enough related to characterized relatives to be identified 
by BLAST searching [6,7]. A particularly revealing story 
involves  cyclodehydratase­mediated  posttranslational 
modi  fi  cation of cysteine, serine and threonine residues to 
form heterocyclic thiazole and oxazole moieties. For the 
antibacterial  ribosomal  peptide  microcin  B17  from 
Escherichia coli, Walsh and colleagues [8] showed that a 
three­protein  enzyme  complex,  including  cyclode­
hydratase, was required to modify the precursor peptide. 
A study by our group [6] on the patellamides, small hetero­
cyclic ribosomal peptides from cyanobacterial symbionts 
of marine animals, showed that the biosynthetic pathway 
did not contain a cyclodehydratase or a precursor peptide 
with  significant  sequence  identity  to  microcin  B17, 
despite identical heterocyclization biochemistry. Instead, 
a single­subunit cyclodehydratase was identified. Homo­
lo  gous enzymes have been recognized in the genomes of 
the cyanobacterium Trichodesmium erythraeum (leading 
to  the  discovery  of  a  new  peptide  product  [5,6])  and 
Streptococcus  iniae  (leading  to  the  recognition  of 
streptolysin S as a thiazole­containing product) [6,7].
Using an informatics approach, Dixon and colleagues 
[7]  showed  that  the  cyclodehydratases  that  modify 
microcin B17, patellamides and other classes of peptides 
are  extremely  abundant  in  bacteria  and  are  linked  to 
diverse  other  posttranslational  modifications.  Despite 
extreme  sequence  dissimilarity  among  individual 
members, informatics studies revealed previously cryptic 
homology in the cyclodehydratases. Recently, the impor­
tance of cyclodehydratases in the production of thera­
peutics  has  been  emphasized  by  the  independent 
discovery by several groups that the thiostrepton family 
of antibiotics is also ribosomally synthesized [9].
The study by Haft et al. [1] significantly extends this 
work. The authors searched for gene clusters involved in 
the biosynthesis of what they refer to as thiazole/oxazole­
modified  microcins  (TOMMs)  in  more  than  1,000 
available bacterial genome sequences, specifically search­
ing  for  cyclodehydratase  protein  sequences.  Two  new 
precursor peptide classes were discovered, both of which 
are related to larger proteins. One is related to a non­
catalytic fragment of nitrile hydrolase (NHase) and the 
other to the Nif11 proteins involved in nitrogen fixation. 
Strikingly,  in  some  genomes  the  NHase­like  precursor 
peptide gene clustered with the cyclodehydratase gene, 
whereas in other genomes it was located far away or the 
two  genes  were  even  separated  on  a  plasmid/chromo­
some  pair.  Further  careful  analysis  using  recently 
developed informatics tools has enabled identification of 
a transport protein linked to this system [1]. The NHase­
like  group  of  precursor  peptides  was  found  in 
phylogenetically diverse bacteria, indicating a potentially 
broadly important new class of secondary metabolites.
The  Nif11­related  precursor  peptides  are  particularly 
interesting  because  of  the  potential  relationship  to 
nitrogen fixation. While some Nif11­like precursor genes 
were  linked  to  cyclodehydratase  genes,  others  were 
linked  to  genes  encoding  the  export  machinery.  In  a 
striking  twist,  some  of  the  Nif11­like  precursor  genes 
were  linked  to  genes  for  enzymes  that  carry  out  a 
completely  different  posttranslational  modification  that 
leads  to  a  lantibiotic.  This  result  clearly  shows  that 
microcins  and  lantibiotics,  while  superficially  seeming 
structurally  and  biochemically  dissimilar,  are  actually 
closely linked in their precursors and biosynthesis. Haft 
et al. [1] suggest that further studies of this type will help 
Figure 1. Diversity in ribosomal peptide natural products is 
produced by variety in enzymatic modification and precursor 
peptide hypervariability. (a) Although precursor peptides consist 
of many different apparently unrelated sequence groups, in general 
they contain a relatively conserved leader sequence directing 
enzyme modification (grey) and a hypervariable core sequence 
that encodes the final natural product (red). (b) In this study [1] 
cyclodehydrating and lanthionine-bond forming enzymes were 
analyzed, but other modifying enzymes exist, leading to numerous 
posttranslational modifications. (c) Further derivatization by multiple 
types of enzymes, including proteases that cleave the peptide 
product from the leader peptide, add to the chemical diversity of 
ribosomal peptide natural products.
(a)
(b)
(c)
Leader peptide-core sequence
Xn-Ser/Thr-Xn -Cys-Xn
Cyclodehydration
heterocycles Lanthionine
synthesis
Diverse other
modiﬁcations
R
S
(X)n (X)n (X)n
O
N
H
N
H
N
R
S
(X)n (X)n (X)n
O O
Diverse tailoring  reactions
Bioactive small molecules
C N
N
Schmidt BMC Biology 2010, 8:83 
http://www.biomedcentral.com/1741-7007/8/83
Page 2 of 4to  uncover  numerous  TOMM  (and  other  natural 
product)  orphan  genes.  The  new  informatics  methods 
and ideas developed by the authors will greatly help to 
further define the evolutionary routes and interrelation­
ships in the ribosomal peptide group.
The  functionality  of  the  TOMM  genes  was  demon­
strated  recently  by  van  der  Donk  and  colleagues  [10], 
who  found  Nif11­like  precursor  peptides  and  their 
lantibiotic­pathway  processing  machinery  in  strains  of 
the ubiquitous planktonic marine cyanobacterium Pro­
chloro  coccus.  The  Prochlorococcus  genus  is  responsible 
for  a  large  percentage  of  global  carbon  fixation  and  is 
found  in  tropical  and  subtropical  oceans  around  the 
world. Previously, no natural products had been isolated 
from members of this genus and their genomes are quite 
small and would traditionally be considered unlikely to 
encode many new compounds. However, about 0.5 to 5% 
of  strains  of  Prochlorococcus  and  the  related  genus 
Synechococcus in environmental databases are estimated 
to  encode  lantibiotic  synthesis  [10].  A  single  strain, 
Prochlorococcus  MIT9313,  contained  29  precursor 
peptides that could be modified by a single lantibiotic­
processing enzyme, leading to a natural library of diverse 
natural products in these strains. The paralogous expan­
sion of precursor peptides in Prochlorococcus and other 
species was also recognized by Haft et al. [1]. Altogether, 
these studies indicate that the widespread TOMM group 
identified  by  Haft  et  al.  does  indeed  lead  to  predicted 
new natural products in important bacterial strains. The 
biological role of such peptides remains speculative.
Precursor peptides and natural product diversity
By necessity, an enzyme that is capable of modifying 29 
diverse precursor peptides must exhibit broad substrate 
tolerance.  Indeed,  work  by  numerous  groups  has 
established  that  ribosomal­peptide­modifying  enzymes 
often  accept  numerous  substitutions  in  the  core 
sequences  of  precursor  peptides,  as  long  as  the  leader 
sequences  are  somewhat  conserved.  This  feature  has 
allowed  both  in  vivo  and  in  vitro  synthesis  of  diverse 
ribosomal peptide derivatives.
The biological impact of this broad substrate specificity 
has been studied in our lab using the patellamide pathway 
[4]. We examined symbiotic cyanobacteria in 46 different 
marine  animals  from  across  the  tropical  Pacific  and 
showed that the DNA encoding modifying enzymes and 
leader  sequences  were  identical,  within  PCR  error,  in 
these closely related symbiotic strains. However, the core 
sequences were hypervariable, encoding a small library of 
29 different precursor peptides. This population of so­far 
uncultured symbiotic cyanobacteria, which are present in 
numerous  marine  animals,  synthesizes  an  enormous 
diversity  of  natural  products  using  identical  enzymes 
encoded by identical genes.
The Prochlorococcus paper [10] and the work of Haft et 
al. [1], along with other recent advances cited therein, 
reveal that hypervariability in core sequences is a general 
phenomenon with a widespread impact. To the best of 
my  knowledge,  the  presence  of  identical  (at  the  DNA 
sequence  level)  enzymes  and  leader  sequences  with 
hypervariable core sequences in different strains has not 
yet  been  described  beyond  the  symbiotic  Prochloron 
studied in our lab. Nonetheless, strikingly similar stories 
are clearly apparent in the sequence alignments obtained 
by Haft et al. [1] and previous reports. Numerous varia­
tions in modifying enzymes have been discovered pre­
viously and the numbers of known enzymes are expand­
ing.  As  many  of  these  enzymes  apparently  synthesize 
diverse products using hypervariable precursor peptides, 
it is clear that the true structural diversity and biological 
impact of the ribosomal peptide natural products is just 
beginning to be appreciated. The informatics approach 
reported by Haft et al. will be very useful in the quest for 
new ribosomal peptides.
Remaining fundamental questions
The ‘bacteriocins’ have been studied for nearly 90 years, 
yet key questions of broad importance to their biology 
have yet to be addressed. The evolutionary relationships 
between diverse peptide families have yet to be estab­
lished.  More  fundamentally,  the  evolution  of  hyper­
variable  core  sequences  within  very  highly  conserved 
DNA  sequence  backgrounds  has  not  been  examined. 
How  do  bacteria  produce  extreme  variation  in  small 
cassettes of around 9 to 60 nucleotides while the remain­
der of the DNA remains constant? This could be related 
to known phenomena such as pilin variation, but this has 
yet to be established. As such core variation is clearly a 
general  phenomenon  in  bacteria,  it  would  be  useful  to 
determine  its  mechanism.  Finally,  although  the  roles  of 
some groups of bacteriocins have been extensively studied 
and mathematically modeled, we do not yet understand 
the  biological  roles  of  most  of  them.  In  developing 
methods  to  find  and  analyze  precursor  and  enzyme 
relationships, the work of Haft and co­workers will greatly 
aid studies to answer these fundamental questions.
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